Medicare now penalizes hospitals for blood culture contamination.
H.R. 5275 — Diagnostic Accuracy in Sepsis Act of 2025 · Filed by Mike Kelly (R-PA) · 7 cosponsors · Introduced Sep 10, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill amends Medicare law to classify blood culture contamination as a hospital-acquired condition (HAC) starting in fiscal year 2026. Hospitals will be penalized financially if their blood culture contamination rates exceed 1%, creating a financial incentive to reduce contamination during patient care.
Why we flagged it
The bill uses Medicare payment penalties to incentivize hospitals to reduce blood culture contamination, a known source of hospital-acquired infections. It is a regulatory safety measure, not a subsidy or carve-out.
What the text implies
- Hospitals with higher baseline contamination rates may face steeper financial pressure to invest in lab quality improvements, potentially widening disparities between well-resourced and under-resourced facilities.
- The 1% threshold is set by the Secretary; if set too low relative to current industry baseline, it could trigger widespread penalties before hospitals have time to implement remediation.
The full analysis lists 3 implications of this text.
Who it affects
Patients benefit from hospitals having financial incentive to reduce blood culture contamination, a serious infection risk. The penalty structure aligns hospital financial interests with patient safety by making contamination reduction economically necessary rather than optional.